We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evolving Considerations in the Treatment and Management of Advanced Non-Small Cell Lung Cancer.
- Authors
Socinski, Mark A.
- Abstract
Targeted therapies are the first-line therapy of choice for patients with advanced non-small cell lung cancer (NSCLC) who have targetable tumor mutations, but immunotherapy alone, or in combination with chemotherapy, is the first-line choice for most patients with NSCLC. Both immunotherapy and targeted therapies have improved outcomes in advanced-stage NSCLC.
- Subjects
THERAPEUTIC use of antineoplastic agents; CONTINUING education units; IMMUNOTHERAPY; TREATMENT effectiveness; CANCER chemotherapy; LUNG cancer; GENETIC mutation
- Publication
Journal of Managed Care Medicine, 2024, Vol 27, Issue 2, p49
- ISSN
1094-1525
- Publication type
Article